Far Infrared Radiation Treatment for Prostate Cancer

Sponsor

GAAD Medical Research Institute Inc. (Other)

Overall Status

Unknown status

CT.gov ID

NCT00573820

Collaborator

(none)

Enrollment

Location

Arm

Duration (Months)

0.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

A study to determine the use of far infrared radiation for the treatment of prostate cancer.

Condition or Disease	Intervention/Treatment	Phase
Prostatic Neoplasms	Radiation: Far Infrared Radiation	Phase 1

Detailed Description

Our initial assessment indicates that electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to cure a number of diseases, including prostate cancer.

Study Design

Study Type:

Interventional

Actual Enrollment :

4 participants

Allocation:

Non-Randomized

Intervention Model:

Single Group Assignment

Masking:

None (Open Label)

Primary Purpose:

Treatment

Official Title:

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Prostate Cancer

Study Start Date :

Jan 1, 2006

Actual Primary Completion Date :

Feb 1, 2008

Anticipated Study Completion Date :

Dec 1, 2008

Arms and Interventions

Arm	Intervention/Treatment
Other: 1	Radiation: Far Infrared Radiation Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each treatment session.

Arm

Intervention/Treatment

Other: 1

Radiation: Far Infrared Radiation

Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each treatment session.

Outcome Measures

Primary Outcome Measures

The primary end point is to determine the therapeutic effects of far infrared radiation on Prostate Cancer. [2 years and 6 months]

Secondary Outcome Measures

The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other types of cancer (Bladder and Testis). [2 years and 6 months]